Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLADIATOR: Ladarixin in Recent Onset Type 1 Diabetes
NCT04628481Phase 2Terminated
- Sponsor
- Dompé
- Start
- Jan 2021
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 8
01
Overview
A Phase 2 trial of ladarixin in type 1 diabetes mellitus (T1D), sponsored by Dompé. Started Jan 2021; status: terminated.
02
Drugs
ladarixin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT04628481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04628481.